WellfullyASX:WFLOA Days Inventory is 33,698.63 as of Dec. 2023, which is 84041% above its 10-year median of 40.05. The stock has 7 warning signs investors should review.
Days Inventory is also known as Days Sales of Inventory (DSI). Wellfully's Average Total Inventories for the
six
months ended in Dec. 2023 was A$1.85 Mil. Wellfully's Cost of Goods Sold for the
six
months ended in Dec. 2023 was A$0.01 Mil.
Hence, Wellfully's Days Inventory for the
six
months ended in Dec. 2023 was 33,698.63.
The historical rank and industry rank for Wellfully's Days Inventory or its related term are showing as below:
ASX:WFLOA'
s Days Inventory Range Over the Past 10 Years
Min: 38.34 Med: 40.05 Max: 242.12
Current: 1053.31
During the past 13 years, Wellfully's highest Days Inventory was 242.12. The lowest was 38.34. And the median was 40.05.
ASX:WFLOA's Days Inventory is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 68.88
vs ASX:WFLOA: 1053.31
Wellfully's Days Inventory
increased
from Dec. 2022 (201.09) to Dec. 2023 (33,698.63).
It might indicate that Wellfully's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Wellfully's Inventory Turnover for the
six
months ended in Dec. 2023 was 0.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wellfully's Inventory-to-Revenue for the
six
months ended in Dec. 2023 was 22.52.
Wellfully (ASX:WFLOA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Wellfully's Inventory Turnover for the
six
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wellfully's Inventory to Revenue for the
six
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Wellfully Days Inventory Related Terms
Wellfully Days Inventory Historical Data
* Premium members only.
The historical data trend for Wellfully's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:WFLOA vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Wellfully's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellfully Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wellfully's Days Inventory distribution charts can be found below:
* The bar in red indicates where Wellfully's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellfully (ASX:WFLOA) has a Days Inventory of 33,698.63 as of Dec. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wellfully and its competitors. This is 84041% above median its historical median of 40.05. Over the past decade, Wellfully's Days Inventory has ranged from 38.34 to 242.12.
Is Wellfully's Days Inventory too high?
Wellfully's current Days Inventory of 33,698.63 is 84041% above median its 10-year median of 40.05. Over the past 10 years, this metric has ranged from a low of 38.34 to a high of 242.12. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Wellfully's value of 33,698.63 is 48823.7% above this industry median.
How does Wellfully's Days Inventory compare to TMO and DHR?
Wellfully's Days Inventory of 33,698.63 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Inventory is 68.88. Wellfully's value of 33,698.63 is 48823.7% above this benchmark. Historically, Wellfully's own Days Inventory has ranged from 38.34 to 242.12 over the past decade. While the company's 10-year median is 40.05 vs. the industry median of 68.88, Wellfully has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 178 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wellfully's current Days Inventory of 33,698.63 is 48823.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wellfully and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellfully's current Days Inventory is 33,698.63, which is 84041% above median its own 10-year median of 40.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellfully stock overvalued right now?
Wellfully (ASX:WFLOA) has a current Days Inventory of 33,698.63. The current Days Inventory is 33,698.63, which is 84041% above median its 10-year median of 40.05 and 48823.7% above the Medical Diagnostics & Research industry median of 68.88. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Wellfully (ASX:WFLOA), the current Days Inventory is 33,698.63 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellfully Ltd is engaged in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely the development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of its revenue from Europe and also has a presence in Japan. It serves the Pharmaceutical; Cosmetics Skincare and Consumer Healthcare industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WFLOA has been successfully added to your 